ACE inhibitors or AT-1 antagonists – which is OPTIMAAL after acute myocardial infarction?

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.3, 2003-03, pp. : 407-409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Use of ACE‐Inhibitors after Myocardial Infarction

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 3, 2002-09 ,pp. : 232-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

ACE Inhibitors after Myocardial Infarction: Clinical and Economic Considerations

By Davie A.P.  

PharmacoEconomics, Vol. 17, Iss. 3, 2000-03 ,pp. : 237-243

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and β-Blockers: Subanalysis of the EPHESUS

By Zhang Zefeng   Mahoney Elizabeth M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 55-63

Adis International

Access to resources Recommend Favorite

Effects of Two Different ACE Inhibitors, Captopril and Delapril, in the Early Phases of Acute Anterior Myocardial Infarction

By Di Pasquale P.  

Clinical Drug Investigation, Vol. 17, Iss. 5, 1999-05 ,pp. : 347-355

Adis International

Access to resources Recommend Favorite

Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarction

By Ferguson James J   Vaisman Dan  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 1965-1976

Informa Healthcare

Access to resources Recommend Favorite